- Home
- TYGO vs VNRX Comparison
TYGO vs VNRX Comparison
Compare TYGO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- VNRX
- Stock Information
- Founded
- TYGO 2007
- VNRX N/A
- Country
- TYGO United States
- VNRX United States
- Employees
- TYGO N/A
- VNRX N/A
- Industry
- TYGO Semiconductors
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TYGO Technology
- VNRX Health Care
- Exchange
- TYGO Nasdaq
- VNRX Nasdaq
- Market Cap
- TYGO 58.9M
- VNRX 59.6M
- IPO Year
- TYGO N/A
- VNRX N/A
- Fundamental
- Price
- TYGO $0.97
- VNRX $0.63
- Analyst Decision
- TYGO Buy
- VNRX Strong Buy
- Analyst Count
- TYGO 3
- VNRX 4
- Target Price
- TYGO $3.00
- VNRX $4.17
- AVG Volume (30 Days)
- TYGO 321.1K
- VNRX 154.8K
- Earning Date
- TYGO 02-11-2025
- VNRX 11-14-2024
- Dividend Yield
- TYGO N/A
- VNRX N/A
- EPS Growth
- TYGO N/A
- VNRX N/A
- EPS
- TYGO N/A
- VNRX N/A
- Revenue
- TYGO $45,985,000.00
- VNRX $1,285,827.00
- Revenue This Year
- TYGO N/A
- VNRX $71,446.31
- Revenue Next Year
- TYGO $57.24
- VNRX N/A
- P/E Ratio
- TYGO N/A
- VNRX N/A
- Revenue Growth
- TYGO N/A
- VNRX 97.50
- 52 Week Low
- TYGO $0.76
- VNRX $0.43
- 52 Week High
- TYGO $2.12
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- TYGO 53.32
- VNRX 48.89
- Support Level
- TYGO $0.76
- VNRX $0.61
- Resistance Level
- TYGO $0.89
- VNRX $0.65
- Average True Range (ATR)
- TYGO 0.17
- VNRX 0.05
- MACD
- TYGO -0.00
- VNRX 0.00
- Stochastic Oscillator
- TYGO 24.37
- VNRX 38.10
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.